Characterization of rpoB mutations in rifampin-resistant clinical isolates of Mycobacterium tuberculosis from turkey by DNA sequencing and line probe assay

被引:124
作者
Cavusoglu, C [1 ]
Hilmioglu, S
Guneri, S
Bilgic, A
机构
[1] Ege Univ, Sch Med, Dept Microbiol & Clin Microbiol, TR-35100 Izmir, Turkey
[2] Reg TB Lab, Izmir, Turkey
关键词
D O I
10.1128/JCM.40.12.4435-4438.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mutations in an 81-bp region of the rpoB gene associated with rifampin resistance were studied in 41 rifampin-resistant clinical strains of Mycobacterium tuberculosis isolated in Turkey. Fourteen different rpoB alleles, three of which had not been reported before, were found. A reverse hybridization-based line probe assay (the Inno-LiPA Rif.TB test) for rapid detection of the mutations was evaluated with these isolates. Rifampin resistance was correctly identified in 23 of 41 isolates (56.1%) with the kit's R probes specific for these mutations. Seventeen of 41 isolates (41.5%) yielded hybridization patterns, with at least one negative signal obtained with the S probes for the wild type. One isolate was identified as rifampin sensitive by the line probe assay. The rate of concordance of the results of the line probe assay with the results of the in vitro susceptibility test was high (97.6%). These results demonstrate that the line probe assay kit may be useful for the rapid diagnosis of rifampin-resistant tuberculosis.
引用
收藏
页码:4435 / 4438
页数:4
相关论文
共 24 条
  • [1] Barfai Z, 2001, J CLIN MICROBIOL, V39, P3736
  • [2] Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis
    Billington, OJ
    McHugh, TD
    Gillespie, SH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 1866 - 1869
  • [3] The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis -: a molecular story
    Drobniewski, FA
    Wilson, SM
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 1998, 47 (03) : 189 - 196
  • [4] Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country
    Dye, C
    Scheele, S
    Dolin, P
    Pathania, V
    Raviglione, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07): : 677 - 686
  • [5] TREATMENT OF 171 PATIENTS WITH PULMONARY TUBERCULOSIS RESISTANT TO ISONIAZID AND RIFAMPIN
    GOBLE, M
    ISEMAN, MD
    MADSEN, LA
    WAITE, D
    ACKERSON, L
    HORSBURGH, CR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) : 527 - 532
  • [6] GUNERI S, 2002, TORAKS DERG, V3, P77
  • [7] Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates
    Heep, M
    Brandstätter, B
    Rieger, U
    Lehn, N
    Richter, E
    Rüsch-Gerdes, S
    Niemann, S
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) : 107 - 110
  • [8] Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis
    Heep, M
    Rieger, U
    Beck, D
    Lehn, N
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) : 1075 - 1077
  • [9] Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay
    Hirano, K
    Abe, C
    Takahashi, M
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (08) : 2663 - 2666
  • [10] CHARACTERIZATION BY AUTOMATED DNA-SEQUENCING OF MUTATIONS IN THE GENE (RPOB) ENCODING THE RNA-POLYMERASE BETA-SUBUNIT IN RIFAMPIN-RESISTANT MYCOBACTERIUM-TUBERCULOSIS STRAINS FROM NEW-YORK-CITY AND TEXAS
    KAPUR, V
    LI, LL
    IORDANESCU, S
    HAMRICK, MR
    WANGER, A
    KREISWIRTH, BN
    MUSSER, JM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (04) : 1095 - 1098